SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001958829-24-000001
Filing Date
2024-01-19
Accepted
2024-01-19 06:19:42
Documents
1

Document Format Files

Seq Description Document Type Size
1 schedule13g-exitfiling.htm SC 13G/A 24907
  Complete submission text file 0001958829-24-000001.txt   26575
Mailing Address 217 W. MAIN STREET SOMERVILLE NJ 08876
Business Address 217 W. MAIN STREET SOMERVILLE NJ 08876 908-370-5102
ZyVersa Therapeutics, Inc. (Subject) CIK: 0001859007 (see all company filings)

IRS No.: 862685744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-93211 | Film No.: 24543669
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 4/F 16-17 LS-RO 91BEON-GIL DONGAN-GU ANYANG, GYEONGGI M5 14042
Business Address 4/F 16-17 LS-RO 91BEON-GIL DONGAN-GU ANYANG, GYEONGGI M5 14042 82 (31) 4558600
INCON Co., Ltd. (Filed by) CIK: 0001958829 (see all company filings)

IRS No.: 000000000 | State of Incorp.: M5 | Fiscal Year End: 1231
Type: SC 13G/A